CN1679933A - 一种自乳化疫苗佐剂及其制备方法 - Google Patents
一种自乳化疫苗佐剂及其制备方法 Download PDFInfo
- Publication number
- CN1679933A CN1679933A CN 200510037639 CN200510037639A CN1679933A CN 1679933 A CN1679933 A CN 1679933A CN 200510037639 CN200510037639 CN 200510037639 CN 200510037639 A CN200510037639 A CN 200510037639A CN 1679933 A CN1679933 A CN 1679933A
- Authority
- CN
- China
- Prior art keywords
- adjuvant
- weight
- vaccine
- described vaccine
- sorbester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012646 vaccine adjuvant Substances 0.000 title claims description 27
- 229940124931 vaccine adjuvant Drugs 0.000 title claims description 27
- 238000002360 preparation method Methods 0.000 title claims description 7
- 239000002671 adjuvant Substances 0.000 claims abstract description 38
- 239000004094 surface-active agent Substances 0.000 claims abstract description 18
- 239000007957 coemulsifier Substances 0.000 claims abstract description 13
- 239000003921 oil Substances 0.000 claims description 28
- 235000019198 oils Nutrition 0.000 claims description 27
- -1 polyoxyethylene Polymers 0.000 claims description 15
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 11
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 11
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 11
- 239000005642 Oleic acid Substances 0.000 claims description 11
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 11
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 11
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 9
- 230000001804 emulsifying effect Effects 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 8
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 5
- NWGKJDSIEKMTRX-MDZDMXLPSA-N Sorbitan oleate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(O)C1OCC(O)C1O NWGKJDSIEKMTRX-MDZDMXLPSA-N 0.000 claims description 5
- 229960003511 macrogol Drugs 0.000 claims description 5
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 5
- 229920000053 polysorbate 80 Polymers 0.000 claims description 5
- PRXRUNOAOLTIEF-WUOFIQDXSA-N sorbitan trioleate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C\CCCCCCCC)C1OCC(O)C1OC(=O)CCCCCCC\C=C\CCCCCCCC PRXRUNOAOLTIEF-WUOFIQDXSA-N 0.000 claims description 5
- 239000000600 sorbitol Substances 0.000 claims description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 claims description 4
- 125000005456 glyceride group Chemical group 0.000 claims description 4
- 239000000787 lecithin Substances 0.000 claims description 4
- 235000010445 lecithin Nutrition 0.000 claims description 4
- 229940067606 lecithin Drugs 0.000 claims description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical class CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 claims description 3
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 claims description 3
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 claims description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 2
- HVUMOYIDDBPOLL-UHFFFAOYSA-N 2-(3,4-Dihydroxyoxolan-2-yl)-2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)C1OCC(O)C1O HVUMOYIDDBPOLL-UHFFFAOYSA-N 0.000 claims description 2
- IJCWFDPJFXGQBN-UHFFFAOYSA-N 2-[4-Hydroxy-3-(octadecanoyloxy)oxolan-2-yl]-2-(octadecanoyloxy)ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)C1OCC(O)C1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-UHFFFAOYSA-N 0.000 claims description 2
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 claims description 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 2
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 claims description 2
- 229920001219 Polysorbate 40 Polymers 0.000 claims description 2
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 2
- 229920002651 Polysorbate 85 Polymers 0.000 claims description 2
- 229960002903 benzyl benzoate Drugs 0.000 claims description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 2
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 claims description 2
- 229940093471 ethyl oleate Drugs 0.000 claims description 2
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 2
- 239000002480 mineral oil Substances 0.000 claims description 2
- 235000010446 mineral oil Nutrition 0.000 claims description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 2
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 claims description 2
- 229920001993 poloxamer 188 Polymers 0.000 claims description 2
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 claims description 2
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 claims description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims description 2
- 229920000136 polysorbate Polymers 0.000 claims description 2
- 229940101027 polysorbate 40 Drugs 0.000 claims description 2
- 229940113124 polysorbate 60 Drugs 0.000 claims description 2
- 229940113171 polysorbate 85 Drugs 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 229960005486 vaccine Drugs 0.000 abstract description 30
- 239000000843 powder Substances 0.000 description 33
- 239000000839 emulsion Substances 0.000 description 24
- 239000000427 antigen Substances 0.000 description 10
- 102000036639 antigens Human genes 0.000 description 10
- 108091007433 antigens Proteins 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 230000008676 import Effects 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 4
- 230000005847 immunogenicity Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000013112 stability test Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 229940031551 inactivated vaccine Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- RNMDNPCBIKJCQP-UHFFFAOYSA-N 5-nonyl-7-oxabicyclo[4.1.0]hepta-1,3,5-trien-2-ol Chemical compound C(CCCCCCCC)C1=C2C(=C(C=C1)O)O2 RNMDNPCBIKJCQP-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002766 immunoenhancing effect Effects 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229940031626 subunit vaccine Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
乳剂 | 进口佐剂(206) | 自制佐剂(实施例4) | 自制佐剂(实施例3) |
外观 | 均匀乳液 | 均匀乳液 | 均匀乳液 |
颜色 | 浅粉红 | 乳白 | 乳白 |
粘度 | 4′22″ | 4′23″ | 4′20″ |
离心 | 均匀一致 | 均匀一致 | 均匀一致 |
放置时间 | 进口佐剂(206) | 自制佐剂(实施例4) | 自制佐剂(实施例3) |
0天 | 均匀粉红色 | 均匀粉红色 | 均匀粉红色 |
5天 | 均匀粉红色 | 均匀粉红色 | 均匀粉红色 |
10天 | 均匀粉红色 | 均匀粉红色 | 均匀粉红色 |
1个月 | 均匀粉红色 | 均匀粉红色 | 均匀粉红色 |
2个月 | 均匀粉红色 | 均匀粉红色 | 均匀粉红色 |
3个月 | 均匀粉红色 | 均匀粉红色 | 均匀粉红色 |
6个月 | 均匀粉红色 | 均匀粉红色 | 均匀粉红色 |
10个月6天 | 见有分层 | 均匀粉红色 | 均匀粉红色 |
11个月22天 | / | 见有分层 | 均匀粉红色 |
12个月18天 | / | / | 见有分层 |
放置时间 | 进口佐剂(206) | 自制佐剂(实施例4) | 自制佐剂(实施例3) |
0天 | 均匀粉红色 | 均匀粉红色 | 均匀粉红色 |
5天 | 均匀粉红色 | 均匀粉红色 | 均匀粉红色 |
8天 | 见有分层 | 均匀粉红色 | 均匀粉红色 |
36天 | / | 见有分层 | 均匀粉红色 |
40天 | / | / | 见有分层 |
项目 | 进口佐剂(206) | 自制佐剂(实施例4) | 自制佐剂(实施例3) |
动物数量 | 10 | 10 | 10 |
发病情况 | 0/10 | 0/10 | 0/10 |
保护情况 | 10/10 | 10/10 | 10/10 |
成分 | 重量百分比(%) |
聚氧乙烯氢化蓖麻油 | 5 |
吐温80 | 6 |
司盘80 | 6 |
司盘85 | 4 |
聚乙二醇200 | 6 |
7号白油 | 73 |
成分 | 质量百分比(%) |
吐温80 | 6 |
乳化剂OP | 4 |
单油酸甘油酯 | 5 |
司盘83 | 4 |
油酸 | 6 |
花生油 | 5 |
10号白油 | 70 |
成分 | 质量百分比(%) |
单油酸缩山梨醇酯 | 5 |
Labrasol | 6 |
司盘80 | 4 |
司盘85 | 6 |
乙酸 | 6 |
1号白油 | 73 |
成分 | 质量百分比(%) |
吐温80 | 5 |
Labrasol | 6 |
司盘80 | 4 |
司盘85 | 7 |
油酸 | 7 |
1号白油 | 71 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100376398A CN1320924C (zh) | 2005-01-07 | 2005-01-07 | 一种自乳化疫苗佐剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100376398A CN1320924C (zh) | 2005-01-07 | 2005-01-07 | 一种自乳化疫苗佐剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1679933A true CN1679933A (zh) | 2005-10-12 |
CN1320924C CN1320924C (zh) | 2007-06-13 |
Family
ID=35066931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100376398A Expired - Fee Related CN1320924C (zh) | 2005-01-07 | 2005-01-07 | 一种自乳化疫苗佐剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1320924C (zh) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102293743A (zh) * | 2010-06-24 | 2011-12-28 | 辽宁成大生物股份有限公司 | 一种脂质微球组合物 |
CN103610641A (zh) * | 2013-11-29 | 2014-03-05 | 绵阳高新区百诺吉生物科技有限公司 | 兽用疫苗用双相油乳佐剂及其制作方法 |
CN103816537A (zh) * | 2014-01-26 | 2014-05-28 | 乾元浩生物股份有限公司 | 一种纳米佐剂及其制备方法 |
CN104398478A (zh) * | 2014-11-03 | 2015-03-11 | 江苏省农业科学院 | 兽用药物的复乳型载体及其应用 |
CN105854014A (zh) * | 2015-01-22 | 2016-08-17 | 中牧实业股份有限公司 | 一种不含聚氧乙烯基乳化剂的疫苗佐剂及其动物疫苗 |
CN106267184A (zh) * | 2016-03-03 | 2017-01-04 | 呼和浩特市佐瑞特生物科技有限责任公司 | 一种水包油包水型乳化剂及其用途和使用方法 |
KR20170030175A (ko) | 2015-09-09 | 2017-03-17 | 강원대학교산학협력단 | 즉시 사용가능한 마이크로에멀젼 기반의 비강내 면역화용 면역보강제 조성물 |
CN106511996A (zh) * | 2016-11-04 | 2017-03-22 | 江苏省农业科学院 | 用于口蹄疫疫苗的复乳型佐剂及其制备方法 |
CN107551268A (zh) * | 2016-06-30 | 2018-01-09 | 国年实业有限公司 | 禽类新城病疫苗用佐剂及其制备方法 |
CN110101661A (zh) * | 2019-05-21 | 2019-08-09 | 肇庆大华农生物药品有限公司 | 一种可快速产生抗体的油乳剂灭活疫苗配方及其制备方法 |
CN110392690A (zh) * | 2017-02-24 | 2019-10-29 | 默沙东公司 | 肺炎球菌缀合物疫苗制剂 |
CN112641939A (zh) * | 2020-12-28 | 2021-04-13 | 吉林冠界生物技术有限公司 | 油包水型复合佐剂及其制备方法和应用、疫苗的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69636889T2 (de) * | 1995-11-30 | 2007-12-06 | Nof Corp. | Öladjuvierter Impfstoff und Verfahren zu seiner Herstellung |
WO1999056776A2 (en) * | 1998-05-07 | 1999-11-11 | Corixa Corporation | Adjuvant composition and methods for its use |
AU769539B2 (en) * | 1999-01-29 | 2004-01-29 | Zoetis Services Llc | Adjuvants for use in vaccines |
-
2005
- 2005-01-07 CN CNB2005100376398A patent/CN1320924C/zh not_active Expired - Fee Related
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102293743A (zh) * | 2010-06-24 | 2011-12-28 | 辽宁成大生物股份有限公司 | 一种脂质微球组合物 |
CN102293743B (zh) * | 2010-06-24 | 2013-09-18 | 辽宁成大生物股份有限公司 | 一种脂质微球组合物 |
CN103610641A (zh) * | 2013-11-29 | 2014-03-05 | 绵阳高新区百诺吉生物科技有限公司 | 兽用疫苗用双相油乳佐剂及其制作方法 |
CN103816537A (zh) * | 2014-01-26 | 2014-05-28 | 乾元浩生物股份有限公司 | 一种纳米佐剂及其制备方法 |
CN104398478A (zh) * | 2014-11-03 | 2015-03-11 | 江苏省农业科学院 | 兽用药物的复乳型载体及其应用 |
CN104398478B (zh) * | 2014-11-03 | 2017-05-10 | 江苏省农业科学院 | 兽用药物的复乳型载体及其应用 |
CN105854014A (zh) * | 2015-01-22 | 2016-08-17 | 中牧实业股份有限公司 | 一种不含聚氧乙烯基乳化剂的疫苗佐剂及其动物疫苗 |
KR20170030175A (ko) | 2015-09-09 | 2017-03-17 | 강원대학교산학협력단 | 즉시 사용가능한 마이크로에멀젼 기반의 비강내 면역화용 면역보강제 조성물 |
CN106267184A (zh) * | 2016-03-03 | 2017-01-04 | 呼和浩特市佐瑞特生物科技有限责任公司 | 一种水包油包水型乳化剂及其用途和使用方法 |
CN106267184B (zh) * | 2016-03-03 | 2020-01-21 | 彭建彪 | 一种水包油包水型乳化剂及其用途和使用方法 |
CN107551268A (zh) * | 2016-06-30 | 2018-01-09 | 国年实业有限公司 | 禽类新城病疫苗用佐剂及其制备方法 |
CN106511996B (zh) * | 2016-11-04 | 2019-09-10 | 江苏省农业科学院 | 用于口蹄疫疫苗的复乳型佐剂及其制备方法 |
CN106511996A (zh) * | 2016-11-04 | 2017-03-22 | 江苏省农业科学院 | 用于口蹄疫疫苗的复乳型佐剂及其制备方法 |
CN110392690A (zh) * | 2017-02-24 | 2019-10-29 | 默沙东公司 | 肺炎球菌缀合物疫苗制剂 |
EP3585803A4 (en) * | 2017-02-24 | 2020-11-11 | Merck Sharp & Dohme Corp. | PNEUMOCOCCIC CONJUGATE VACCINE FORMULATIONS |
CN110392690B (zh) * | 2017-02-24 | 2024-01-30 | 默沙东有限责任公司 | 肺炎球菌缀合物疫苗制剂 |
CN110101661A (zh) * | 2019-05-21 | 2019-08-09 | 肇庆大华农生物药品有限公司 | 一种可快速产生抗体的油乳剂灭活疫苗配方及其制备方法 |
CN110101661B (zh) * | 2019-05-21 | 2022-01-21 | 肇庆大华农生物药品有限公司 | 一种可快速产生抗体的油乳剂灭活疫苗配方及其制备方法 |
CN112641939A (zh) * | 2020-12-28 | 2021-04-13 | 吉林冠界生物技术有限公司 | 油包水型复合佐剂及其制备方法和应用、疫苗的制备方法 |
CN112641939B (zh) * | 2020-12-28 | 2024-04-02 | 吉林冠界生物技术有限公司 | 油包水型复合佐剂及其制备方法和应用、疫苗的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1320924C (zh) | 2007-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1679933A (zh) | 一种自乳化疫苗佐剂及其制备方法 | |
CN104147599B (zh) | 一种疫苗佐剂、其制备方法及应用 | |
AU597462B2 (en) | Sustained release growth hormone compositions for parenteral administration and their use | |
CN1088599C (zh) | 包括一种抗原或包含氨基酸序列化合物的体内发生器的治疗性组合物 | |
CN103071153B (zh) | 一种兽用疫苗的即用型佐剂、制备及其应用 | |
CN100384473C (zh) | 油佐剂疫苗 | |
CN1168629A (zh) | 疫苗组合物佐剂 | |
CN1141810A (zh) | 病毒疫苗佐剂 | |
CN104470938A (zh) | 二糖合成脂质化合物及其用途 | |
RU2015106791A (ru) | Иммуногенные композиции | |
CN101690809A (zh) | 一种蜂胶与黄芪多糖复方纳米乳佐剂及其制备方法和应用 | |
CN101670103A (zh) | 一种复方人参总皂甙和左旋咪唑纳米乳佐剂及其制备方法 | |
CN101703771B (zh) | 一种水包油型复方疫苗佐剂及其制备方法 | |
WO2018227728A1 (zh) | 一种免疫增强剂、口蹄疫灭活疫苗及其制备方法 | |
EP1032419A1 (en) | Saponin adjuvant composition | |
CN102600470A (zh) | 一种复方佐剂、含有该复方佐剂的疫苗及其制备方法 | |
CN102764435B (zh) | 一种猪用亚洲i型口蹄疫病毒灭活疫苗佐剂及制备方法 | |
CN106511995A (zh) | 一种水包油包水型疫苗佐剂及其应用 | |
CN103301456B (zh) | 水包油型酵母β葡聚糖纳米乳佐剂及其制备方法和应用 | |
CN114366810A (zh) | 一种可高效诱导体液和细胞免疫的天然微生物和植物来源复合双佐剂及其制备方法和应用 | |
CN103608041A (zh) | 包含生物性抗原和丙烯酸聚合物的水性组合物 | |
CN106267184A (zh) | 一种水包油包水型乳化剂及其用途和使用方法 | |
CN106176634A (zh) | 一种猪传染性胃肠炎‑流行性腹泻二联弱毒疫苗脂质体稀释液冻干制品及其制备方法 | |
CN113209287B (zh) | 油包水型纳米疫苗佐剂、制备方法及其应用 | |
DE60125007T2 (de) | Schichtförmige und kryogenisch gelagerte Impstoffe und Verfahren zur deren Bereitung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice |
Addressee: Xing Weifan Document name: Notification that Application Deemed not to be Proposed |
|
ASS | Succession or assignment of patent right |
Owner name: CHEN BEINING Free format text: FORMER OWNER: XING WEIFAN Effective date: 20130911 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 210009 NANJING, JIANGSU PROVINCE TO: 211100 NANJING, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130911 Address after: Jiangning District of Nanjing City, Jiangsu province 211100 dry road No. 5 4 floor Patentee after: Chen Beining Address before: 210009 Jiangsu Province, Nanjing City Bridge No. 2 building 12 East Patentee before: Xing Weifan |
|
ASS | Succession or assignment of patent right |
Owner name: NANJING KUIKE BIOPHARMACETICAL CO., LTD. Free format text: FORMER OWNER: CHEN BEINING Effective date: 20140211 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140211 Address after: Jiangning District of Nanjing City, Jiangsu province 211100 dry road No. 5 4 floor Patentee after: Nanjing Hong Ke biotechnology Co Ltd Address before: Jiangning District of Nanjing City, Jiangsu province 211100 dry road No. 5 4 floor Patentee before: Chen Beining |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160629 Address after: Jiangning District of Nanjing City, Jiangsu province 211100 dry road No. 5 4 floor Patentee after: Nanjing Aili Ke Pharmaceutical Co. Ltd. Address before: Jiangning District of Nanjing City, Jiangsu province 211100 dry road No. 5 4 floor Patentee before: Nanjing Hong Ke biotechnology Co Ltd |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070613 Termination date: 20180107 |